Anaplastic Lymphoma Kinase (alk) - Histology

Relevant Publications

Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.

Issue Release: 2024

Understanding the dynamics of TKI-induced changes in the tumor immune microenvironment for improved therapeutic effect.

Issue Release: 2024

Real-World Treatment Patterns and Outcomes Across Three Lines of Therapy in Patients with ALK+ NSCLC.

Issue Release: 2024

ALK-positive Histiocytosis in 12 Asian Children.

Issue Release: 2024

Identification of APPB1 as a substrate for anaplastic lymphoma kinase.

Issue Release: 2024

Post-marketing safety of lorlatinib: a real-world study based on the FDA adverse event reporting system.

Issue Release: 2024

Population modeling analyses of crizotinib in pediatric patients with ALK-positive advanced cancers.

Issue Release: 2024

Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications.

Issue Release: 2024

Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma.

Issue Release: 2024

Multi-index comprehensive evaluation of the efficacy and response mechanism of immunotherapy in non-small cell lung cancer.

Issue Release: 2024

Blockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis.

Issue Release: 2024

Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival.

Issue Release: 2024

The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates.

Issue Release: 2024

Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line.

Issue Release: 2024

Localized anaplastic lymphoma kinase-positive histiocytosis in a cerebellar hemisphere with long-term treatment: illustrative case.

Issue Release: 2024

Partial response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic V600EMT colon cancer patient with acquired amplification and fusion: a case report.

Issue Release: 2024

Wild-Type Anaplastic Lymphoma Kinase Expression in Solitary Pulmonary Nodules: A Potential Marker for Primary Lung Squamous Cell Carcinoma in Patients With Previous Neck Squamous Cell Carcinoma.

Issue Release: 2024

Successful intracranial response of lorlatinib after resistance with alectinib and brigatinib in patients with ALK-positive lung adenocarcinoma: Implications of CNS penetration rate of brigatinib.

Issue Release: 2024

EML4-ALK G1202R and EML4-ALK L1196M mutations induce crizotinib resistance in non-small cell lung cancer cells through activating epithelial-mesenchymal transition mediated by MDM2/MEK/ERK signal axis.

Issue Release: 2024

Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521.

Issue Release: 2024

How Do Cancerous Cells Differ from Normal Cells?

How are BMPs Studied in Histology?

Where is White Matter Located?

How Can Histology Aid in Developing More Effective Herbicides?

What are the Key Steps in Statistical Analysis?

What are the Primary Sources of Infection?

What are the Future Directions in Lipid Marker Research?

How is Granulation Tissue Identified in Histological Studies?

How Do They Support Laboratory Technicians and Pathologists?

What are Catecholamines?

Anaplastic Lymphoma Kinase (alk) - Histology

Relevant Publications

Partnered Content Networks

Relevant Topics